Jeff Dykan has served on the ReWalk board since 2006 and has been its Chairman since 2009. Mr. Dykan has been a director of the corporate general partner of the common general partner of Vitalife and its successor fund, SCP Vitalife, an Israeli venture capital fund, since 2002 and 2007, respectively. Prior to joining Vitalife, from 2001 to 2002, Mr. Dykan was the Chairman and Chief Executive Officer of BitBand Inc. Mr. Dykan is a member of the American Institute of CPAs and holds a B.Sc. in accounting and management and an MBA in computer applications, both from New York University.
CEO & Director
Larry Jasinski has served as Chief Executive Officer and as a member of the ReWalk board since February 2012. From 2005 until 2012, Mr. Jasinski served as the President and Chief Executive Officer of Soteira, Inc., a company engaged in development and commercialization of products used to treat individuals with vertebral compression fractures, which was acquired by Globus Medical in 2012. From 2001 to 2005, Mr. Jasinski was President and Chief Executive Officer of Cortek, Inc., a company that developed next-generation treatments for degenerative disc disease, which was acquired by Alphatec in 2005. From 1985 until 2001, Mr. Jasinski served in multiple sales, research and development, and general management roles at Boston Scientific Corporation. Mr. Jasinski holds a B.Sc. in marketing from Providence College and an MBA from the University of Bridgeport.
Yasushi Ichiki has served on the ReWalk board since 2014. Mr. Ichiki has been the Manager of the Corporate Planning Group, Corporate Planning Division, of Yaskawa Electric Corporation since May 2014. Previously, from February 2010 to April 2014, he served as the General Manager of Corporate Planning, Robotics Division of Yaskawa Europe GmbH. Mr Ichiki holds a B.A. from Yamaguchi University, Japan.
Wayne B. Weisman
Wayne B. Weisman has served on the ReWalk board since 2009. Since 2007, Mr. Weisman has been a director of the corporate general partner of the common general partner of SCP Vitalife. He has also served as a managing member of SCP Vitalife Management Company, LLC, which by contract provides certain management services to the common general partner of SCP Vitalife. Mr. Weisman is Chairman of Recro Pharma, Inc. (Nasdaq: REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain. He also serves on the board of a number of private companies, including Recro Pharma, LZ Therapeutics and Echo 360. He is Chairman of the board of trustees of Young Scholars School. Mr. Weisman holds a B.A. from the University of Pennsylvania and a J.D. from the University of Michigan Law School.
Dr. John William Poduska
Dr. John William Poduska will serve on the ReWalk board starting in September 2014 as an external director. Dr. Poduska currently serves as a director of EXA Corporation (NASDAQ: EXA) where he serves as chairman of the compensation committee and a member of the nominating and governance committee. He also serves as a director on the boards of a number of privately-held companies. Dr. Poduska also served as a director of Novell, Inc. until 2011 and of Anadarko Petroleum Corporation and Safeguard Scientifics, Inc. until 2009. Dr. Poduska was the Chairman of Advanced Visual Systems Inc., a provider of visualization software, from January 1992 to December 2001. From December 1989 until December 1991, Dr. Poduska was President and Chief Executive Officer of Stardent Computer Inc., a computer manufacturer. From December 1985 until December 1989, Dr. Poduska served as Chairman and Chief Executive Officer of Stellar Computer Inc., a computer manufacturer he founded which is the predecessor of Stardent Computer Inc. Prior to founding Stellar Computer, Inc., Dr. Poduska founded Apollo Computer Inc. and Prime Computer, Inc. Dr. Poduska holds a Sc.D. from MIT and an Honorary Doctorate of Humane Letters from Lowell University.
Yohanan Engelhardt has served on our Board since May 2018 and has been the Chairman of our Audit Committee since May 3, 2018. Mr. Engelhardt served as CFO and VP Finance of publicly-traded and private companies for 25 years, including 18 years at ViryaNet, a provider of mobile workforce management software solutions. During his tenure at ViryaNet he oversaw all financial operations, M&A activities, private placements, the company’s IPO and the sale of the company to a large private equity firm in 2014. Since 2015, he has provided CFO services to early-stage companies as well as accounting services to an accounting firm. Mr. Engelhardt holds a B.A. in accounting and economics from the Hebrew University of Jerusalem and a CPA license in the U.S and in Israel. He is a member of the American Institute of Certified Public Accountants and the Institute of Certified Public Accountants in Israel. We believe that Mr. Engelhardt’s extensive background as executive in various public companies provides him the qualifications and skills to serve as a member of our Board.
Randel E. Richner, BSN, MPH began serving on the ReWalk Board as of Nov. 1, 2020. She has over 30 years of experience in health care policy, reimbursement, economics. She has been active in public policy serving as the first industry representative on the Executive Committee of the Medicare Coverage Advisory Committee and currently serves on the Executive Dean’s Advisory Board at the University of Michigan’s School of Public Health. She founded The Neocure Group which provided health economics and reimbursement strategic services to the healthcare industry. Previously she established the global reimbursement functions for Boston Scientific. She holds a Master’s Degree in Public Health and Bachelors in Nursing from the University of Michigan.
Joseph Turk has served on the ReWalk Board since April 2022. Mr. Turk has been an Executive Vice President of Fresenius Medical Care North America since 2019, during which he has served as the President of its Renal Therapies group since July 2021 and as the President of its Home and Critical Care Therapies group from February 2019 until July 2021. He held a number of leadership roles, most recently President, at NxStage Medical, Inc. between 2000 to 2019. Prior to NxStage, Mr. Turk also spent time at Boston Scientific and McKinsey and Company. Mr. Turk holds a B.A. from Wabash College and an M.B.A from the Kellogg Graduate School of Management at Northwestern University.
Hadar Levy started his career at Deloitte LLP, and, since then, has had an extensive career in the medical device industry. He has served in key positions at GE Healthcare, Notal Vision, Amdocs and BrainsWay, where he led financial and commercialization activities and oversaw the implementation of growth and development of key products. Mr. Levy holds a BA in Accounting and Economics, an LLM degree from Bar-Ilan University, and is a Certified Public Accountant.